{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T22:57:45Z","timestamp":1790463465366,"version":"4.1.0"},"reference-count":165,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:00:00Z","timestamp":1790380800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:00:00Z","timestamp":1790380800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Microbiol"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s00203-026-05194-w","type":"journal-article","created":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T09:33:34Z","timestamp":1790415214000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pharmaceutical innovation in advanced nanomedicine for the treatment of hypervirulent and multidrug-resistant Klebsiella pneumoniae infections"],"prefix":"10.1007","volume":"208","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8541-7304","authenticated-orcid":false,"given":"Helal F.","family":"Hetta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fawaz E.","family":"Alanazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanan","family":"Alshareef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghareb M.","family":"Soliman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sultan A.","family":"Almadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ageel F.","family":"Aljuhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salwa Qasim","family":"Bukhari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zinab","family":"Alatawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noura H. Abd","family":"Ellah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9742-4253","authenticated-orcid":false,"given":"Ali M.","family":"Atoom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"El-Maghrabey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7374-9334","authenticated-orcid":false,"given":"Yasmin N.","family":"Ramadan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,26]]},"reference":[{"issue":"2","key":"5194_CR1","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1093\/inteam\/vjae031","volume":"21","author":"E Abbate","year":"2025","unstructured":"Abbate E et al (2025) Operationalization of the safe and sustainable by design framework for chemicals and materials: challenges and proposed actions. Integr Environ Assess Manag 21(2):245\u2013262","journal-title":"Integr Environ Assess Manag"},{"issue":"3","key":"5194_CR2","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1007\/s10904-024-03230-0","volume":"35","author":"FE-ZA Abd El-Aziz","year":"2025","unstructured":"Abd El-Aziz FE-ZA et al (2025) Antibacterial and healing potential of Zn-Al LDHs\/cellulose acetate nanocomposite in burns and wounds: a study on earthworms as a human skin model. J Inorg Organomet Polym Mater 35(3):1615\u20131626","journal-title":"J Inorg Organomet Polym Mater"},{"issue":"6","key":"5194_CR3","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1007\/s12247-026-10833-2","volume":"21","author":"MS Abdelaleem","year":"2026","unstructured":"Abdelaleem MS et al (2026) Colistin-loaded PLGA nanoparticles enhance the antibacterial and antibiofilm activity and modulate virulence gene expression in Escherichia Coli. J Pharm Innov 21(6):602","journal-title":"J Pharm Innov"},{"issue":"1","key":"5194_CR4","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13756-019-0536-0","volume":"8","author":"S Abrar","year":"2019","unstructured":"Abrar S et al (2019) Distribution of bla CTX\u2009\u2212\u2009M, bla TEM, bla SHV and bla OXA genes in extended-spectrum-\u03b2-lactamase-producing clinical isolates: a three-year multi-center study from Lahore, Pakistan. Antimicrob Resist Infect Control 8(1):80","journal-title":"Antimicrob Resist Infect Control"},{"issue":"1","key":"5194_CR5","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s13568-023-01619-7","volume":"13","author":"M Adil","year":"2023","unstructured":"Adil M et al (2023) Efficient green silver nanoparticles-antibiotic combinations against antibiotic-resistant bacteria. AMB Express 13(1):115","journal-title":"AMB Express"},{"issue":"2","key":"5194_CR6","doi-asserted-by":"publisher","first-page":"162","DOI":"10.3390\/biology11020162","volume":"11","author":"JJ Aguilera-Correa","year":"2022","unstructured":"Aguilera-Correa JJ et al (2022) Effect of gold nanostars plus amikacin against carbapenem-resistant Klebsiella pneumoniae biofilms. Biology 11(2):162","journal-title":"Biology"},{"issue":"9","key":"5194_CR7","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.1007\/s13346-025-01861-5","volume":"15","author":"R Ahmed","year":"2025","unstructured":"Ahmed R et al (2025) Formulation and clinical translation of inhalable nanomedicines for the treatment and prevention of pulmonary infectious diseases. Drug Delivery Translational Res 15(9):2967\u20132993","journal-title":"Drug Delivery Translational Res"},{"issue":"Special Edition","key":"5194_CR8","first-page":"413","volume":"9","author":"MS Al-Mogbel","year":"2015","unstructured":"Al-Mogbel MS et al (2015) Influence of growth in biofilm in the formation of new biofilm by clinical isolates of Acinetobacter baumannii. J Pure Appl Microbiol 9(Special Edition 1):413\u2013416","journal-title":"J Pure Appl Microbiol"},{"issue":"17","key":"5194_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics15172244","volume":"15","author":"AD Alatawi","year":"2025","unstructured":"Alatawi AD et al (2025) Diagnostic innovations to combat antibiotic resistance in critical care: tools for targeted therapy and stewardship. Diagnostics (Basel) 15(17):2244","journal-title":"Diagnostics (Basel)"},{"issue":"4","key":"5194_CR10","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1007\/s12088-024-01271-0","volume":"64","author":"FAA Algabar","year":"2024","unstructured":"Algabar FAA et al (2024) Antibacterial synergy: assessing the impact of nano zirconium oxide particles in combination with selected antibiotics on Escherichia coli and Klebsiella pneumoniae isolates from urinary tract infections. Indian J Microbiol 64(4):1894\u20131902","journal-title":"Indian J Microbiol"},{"issue":"1","key":"5194_CR11","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s44446-026-00064-4","volume":"34","author":"FM Almufarriji","year":"2026","unstructured":"Almufarriji FM (2026) Nanocarrier-mediated CRISPR-Cas delivery: a novel approach against antibiotic-resistant superbugs. Saudi Pharm J 34(1):5","journal-title":"Saudi Pharm J"},{"issue":"2","key":"5194_CR12","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3390\/jnt6020009","volume":"6","author":"DM AlQurashi","year":"2025","unstructured":"AlQurashi DM et al (2025) Advanced nanoparticles in combating antibiotic resistance: current innovations and future directions. J Nanotheranostics 6(2):9","journal-title":"J Nanotheranostics"},{"key":"5194_CR13","doi-asserted-by":"publisher","first-page":"124567","DOI":"10.1016\/j.ijpharm.2024.124567","volume":"664","author":"AA Alsa\u2019d","year":"2024","unstructured":"Alsa\u2019d AA et al (2024) Optimising intracellular delivery of antibiotic loaded PLGA nanoparticles to macrophages. Int J Pharm 664:124567","journal-title":"Int J Pharm"},{"key":"5194_CR14","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.actbio.2021.09.027","volume":"136","author":"E \u00c1lvarez","year":"2021","unstructured":"\u00c1lvarez E et al (2021) A versatile multicomponent mesoporous silica nanosystem with dual antimicrobial and osteogenic effects. Acta Biomater 136:570\u2013581","journal-title":"Acta Biomater"},{"issue":"7","key":"5194_CR15","doi-asserted-by":"publisher","first-page":"911","DOI":"10.3390\/v17070911","volume":"17","author":"C Anastassopoulou","year":"2025","unstructured":"Anastassopoulou C et al (2025) Armed phages: a new weapon in the battle against antimicrobial resistance. Viruses 17(7):911","journal-title":"Viruses"},{"key":"5194_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.microb.2025.100333","volume":"7","author":"S Asokan","year":"2025","unstructured":"Asokan S et al (2025) Klebsiella pneumoniae: a growing threat in the era of antimicrobial resistance. The Microbe 7:100333","journal-title":"The Microbe"},{"issue":"3","key":"5194_CR17","doi-asserted-by":"publisher","first-page":"421","DOI":"10.3390\/antibiotics11030421","volume":"11","author":"C Aurilio","year":"2022","unstructured":"Aurilio C et al (2022) Mechanisms of action of carbapenem resistance. Antibiotics 11(3):421","journal-title":"Antibiotics"},{"issue":"3","key":"5194_CR18","first-page":"e43","volume":"37","author":"RN Aziz","year":"2025","unstructured":"Aziz RN et al (2025) Bacterial dormancy: strategies and molecular mechanisms for a sleeping beauty system. Reviews Res Med Microbiol 37(3):e43\u2013e55","journal-title":"Reviews Res Med Microbiol"},{"issue":"12","key":"5194_CR19","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.3390\/bios12121155","volume":"12","author":"M Barani","year":"2022","unstructured":"Barani M et al (2022) Recent advances in nanotechnology for the management of Klebsiella pneumoniae\u2013related infections. Biosensors 12(12):1155","journal-title":"Biosensors"},{"key":"5194_CR20","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.3762\/bjnano.16.144","volume":"16","author":"M Bartkowski","year":"2025","unstructured":"Bartkowski M, Calzaferri F, Giordani S (2025) Toward clinical translation of carbon nanomaterials in anticancer drug delivery: the need for standardisation. Beilstein J Nanotechnol 16:2092\u20132104","journal-title":"Beilstein J Nanotechnol"},{"key":"5194_CR21","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.meegid.2016.05.011","volume":"43","author":"B Bedeni\u0107","year":"2016","unstructured":"Bedeni\u0107 B et al (2016) Molecular characterization of class b carbapenemases in advanced stage of dissemination and emergence of class d carbapenemases in Enterobacteriaceae from Croatia. Infect Genet Evol 43:74\u201382","journal-title":"Infect Genet Evol"},{"issue":"16","key":"5194_CR22","doi-asserted-by":"publisher","first-page":"4904","DOI":"10.3390\/s25164904","volume":"25","author":"J Blackshare","year":"2025","unstructured":"Blackshare J et al (2025) Enhancing sensitivity of commercial gold nanoparticle-based lateral flow assays: a comparative study of colorimetric and photothermal approaches. Sensors 25(16):4904","journal-title":"Sensors"},{"issue":"2","key":"5194_CR23","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1089\/mdr.2020.0199","volume":"27","author":"M Boattini","year":"2021","unstructured":"Boattini M et al (2021) Detection of carbapenemase and CTX-M encoding genes directly from bronchoalveolar lavage using the CRE and ESBL ELITe MGB assays: toward early and optimal antibiotic therapy management of critically ill patients with pneumonia. Microb Drug Resist 27(2):241\u2013246","journal-title":"Microb Drug Resist"},{"key":"5194_CR24","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/AAC.00397-20","volume":"64","author":"SE Boyd","year":"2020","unstructured":"Boyd SE et al (2020) Metallo-\u03b2-lactamases: structure, function, epidemiology, treatment options, and the development pipeline. Antimicrob Agents Chemother 64(10). (00397\u2009\u2013\u200920)","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"5194_CR25","doi-asserted-by":"publisher","first-page":"320","DOI":"10.3390\/ph17030320","volume":"17","author":"LAdA Campos","year":"2024","unstructured":"Campos LAdA et al (2024) Ceftazidime\/Tobramycin co-loaded chitosan-coated zein nanoparticles against antibiotic-resistant and biofilm-producing Pseudomonas aeruginosa and Klebsiella pneumoniae. Pharmaceuticals 17(3):320","journal-title":"Pharmaceuticals"},{"key":"5194_CR26","unstructured":"CDC. About Carbapenem-resistant Enterobacterales (CRE) (2025), Available from: https:\/\/www.cdc.gov\/cre\/about\/index.html"},{"issue":"5","key":"5194_CR27","doi-asserted-by":"publisher","DOI":"10.1002\/macp.202100440","volume":"223","author":"Y Chen","year":"2022","unstructured":"Chen Y, Huang Y, Jin Q (2022) Polymeric nanoplatforms for the delivery of antibacterial agents. Macromol Chem Phys 223(5):2100440","journal-title":"Macromol Chem Phys"},{"key":"5194_CR28","doi-asserted-by":"publisher","first-page":"5243","DOI":"10.2147\/IDR.S418523","volume":"16","author":"J Chen","year":"2023","unstructured":"Chen J, Zhang H, Liao X (2023) Hypervirulent Klebsiella pneumoniae. Infect Drug Resist 16:5243\u20135249","journal-title":"Infect Drug Resist"},{"key":"5194_CR29","doi-asserted-by":"publisher","first-page":"953","DOI":"10.3389\/fmicb.2019.00953","volume":"10","author":"U Choi","year":"2019","unstructured":"Choi U, Lee C-R (2019) Distinct roles of outer membrane porins in antibiotic resistance and membrane integrity in Escherichia coli. Front Microbiol 10:953","journal-title":"Front Microbiol"},{"issue":"6","key":"5194_CR30","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.jinf.2006.11.008","volume":"54","author":"DR Chung","year":"2007","unstructured":"Chung DR et al (2007) Emerging invasive liver abscess caused by K1 serotype Klebsiella pneumoniae in Korea. J Infect 54(6):578\u2013583","journal-title":"J Infect"},{"issue":"1","key":"5194_CR31","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/s44321-023-00007-9","volume":"16","author":"VD Cruz","year":"2024","unstructured":"Cruz VD (2024) Pyridylpiperazine efflux pump inhibitor boosts in vivo antibiotic efficacy against K. pneumoniae. EMBO Mol Med 16(1):93\u2013111","journal-title":"EMBO Mol Med"},{"issue":"6","key":"5194_CR32","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.amjms.2020.06.028","volume":"360","author":"F Cruz-L\u00f3pez","year":"2020","unstructured":"Cruz-L\u00f3pez F et al (2020) Acquired genetic elements that contribute to antimicrobial resistance in frequent gram-negative causative agents of healthcare-associated infections. Am J Med Sci 360(6):631\u2013640","journal-title":"Am J Med Sci"},{"key":"5194_CR33","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","volume":"399","author":"S Darboe","year":"2022","unstructured":"Darboe S, Carvaheiro C, Kobeissi E (2022) Articles global burden of bacterial antimicrobial resistance in 2019: a systematic analysis antimicrobial resistance collaborators. Lancet 399:629\u2013655","journal-title":"Lancet"},{"issue":"40","key":"5194_CR34","doi-asserted-by":"publisher","first-page":"25043","DOI":"10.1073\/pnas.2003407117","volume":"117","author":"S David","year":"2020","unstructured":"David S et al (2020) Integrated chromosomal and plasmid sequence analyses reveal diverse modes of carbapenemase gene spread among Klebsiella pneumoniae. Proc Natl Acad Sci U S A 117(40):25043\u201325054","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"29","key":"5194_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202502315","volume":"21","author":"N Desai","year":"2025","unstructured":"Desai N et al (2025) Nanoparticle therapeutics in clinical perspective: classification, marketed products, and regulatory landscape. Small 21(29):2502315","journal-title":"Small"},{"issue":"3","key":"5194_CR36","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1007\/s13346-024-01716-5","volume":"15","author":"M Dias","year":"2025","unstructured":"Dias M et al (2025) Clinical translation and landscape of silver nanoparticles. Drug Delivery Translational Res 15(3):789\u2013797","journal-title":"Drug Delivery Translational Res"},{"issue":"3","key":"5194_CR37","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1007\/s13346-021-01024-2","volume":"12","author":"S \u0110or\u0111evi\u0107","year":"2022","unstructured":"\u0110or\u0111evi\u0107 S et al (2022) Current hurdles to the translation of nanomedicines from bench to the clinic. Drug Deliv Transl Res 12(3):500\u2013525","journal-title":"Drug Deliv Transl Res"},{"issue":"13","key":"5194_CR38","doi-asserted-by":"publisher","first-page":"6222","DOI":"10.3390\/ijms26136222","volume":"26","author":"F Eker","year":"2025","unstructured":"Eker F et al (2025) Green synthesis of silver nanoparticles using plant extracts: a comprehensive review of physicochemical properties and multifunctional applications. Int J Mol Sci 26(13):6222","journal-title":"Int J Mol Sci"},{"issue":"1","key":"5194_CR39","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s43939-025-00489-z","volume":"6","author":"D El-Sayed Ellakwa","year":"2025","unstructured":"El-Sayed Ellakwa D, Ellakwa TE (2025) Biocompatible nanoparticles in medicine: from design to clinical translation. Discover Mater 6(1):28","journal-title":"Discover Mater"},{"key":"5194_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2024.1507274","author":"E Elashkar","year":"2025","unstructured":"Elashkar E et al (2025) Novel silver nanoparticle-based biomaterials for combating Klebsiella pneumoniae biofilms. Front Microbiol. https:\/\/doi.org\/10.3389\/fmicb.2024.1507274","journal-title":"Front Microbiol"},{"key":"5194_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2024.1507274","volume":"15","author":"E Elashkar","year":"2024","unstructured":"Elashkar E et al (2024) Novel silver nanoparticle-based biomaterials for combating Klebsiella pneumoniae biofilms. Front Microbiol 15:1507274","journal-title":"Front Microbiol"},{"key":"5194_CR42","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.jconrel.2022.09.052","volume":"351","author":"E Elhassan","year":"2022","unstructured":"Elhassan E et al (2022) Engineering hybrid nanosystems for efficient and targeted delivery against bacterial infections. J Controlled Release 351:598\u2013622","journal-title":"J Controlled Release"},{"issue":"11","key":"5194_CR43","doi-asserted-by":"publisher","first-page":"801","DOI":"10.3390\/toxics12110801","volume":"12","author":"VA Ershov","year":"2024","unstructured":"Ershov VA, Ershov BG (2024) Effect of silver nanoparticle size on antibacterial activity. Toxics 12(11):801","journal-title":"Toxics"},{"issue":"9","key":"5194_CR44","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/nrmicro.2016.94","volume":"14","author":"H-C Flemming","year":"2016","unstructured":"Flemming H-C et al (2016) Biofilms: an emergent form of bacterial life. Nat Rev Microbiol 14(9):563\u2013575","journal-title":"Nat Rev Microbiol"},{"key":"5194_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/jfb15030058","author":"Y Gan","year":"2024","unstructured":"Gan Y et al (2024) Gold nanoparticle-based colorimetric and fluorescent dual-mode lateral flow immunoassay for SARS-CoV-2 detection. J Funct Biomater. https:\/\/doi.org\/10.3390\/jfb15030058","journal-title":"J Funct Biomater"},{"key":"5194_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.cis.2025.103626","volume":"345","author":"AN Generalova","year":"2025","unstructured":"Generalova AN, Dushina AO (2025) Metal\/metal oxide nanoparticles with antibacterial activity and their potential to disrupt bacterial biofilms: recent advances with emphasis on the underlying mechanisms. Adv Colloid Interface Sci 345:103626","journal-title":"Adv Colloid Interface Sci"},{"issue":"12","key":"5194_CR47","doi-asserted-by":"publisher","DOI":"10.1002\/nano.202400049","volume":"5","author":"A Girma","year":"2024","unstructured":"Girma A et al (2024) Antibacterial capabilities of metallic nanoparticles and influencing factors. Nano Select 5(12):e202400049","journal-title":"Nano Select"},{"key":"5194_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2023.123758","volume":"651","author":"T Gon\u00e7alves","year":"2024","unstructured":"Gon\u00e7alves T et al (2024) Antimicrobial activity of prophage endolysins against critical Enterobacteriaceae antibiotic-resistant bacteria. Int J Pharm 651:123758","journal-title":"Int J Pharm"},{"issue":"5","key":"5194_CR49","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1021\/acsinfecdis.9b00357","volume":"6","author":"A Gonzalez Gomez","year":"2020","unstructured":"Gonzalez Gomez A, Hosseinidoust Z (2020) Liposomes for antibiotic encapsulation and delivery. ACS Infect Dis 6(5):896\u2013908","journal-title":"ACS Infect Dis"},{"key":"5194_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.microb.2025.100436","volume":"8","author":"O Grari","year":"2025","unstructured":"Grari O et al (2025) A comprehensive review on biofilm-associated infections: mechanisms, diagnostic challenges, and innovative therapeutic strategies. Microbe 8:100436","journal-title":"Microbe"},{"issue":"4","key":"5194_CR51","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/s41578-024-00658-1","volume":"9","author":"M Hadjidemetriou","year":"2024","unstructured":"Hadjidemetriou M, Mahmoudi M, Kostarelos K (2024) vivo biomolecule corona and the transformation of a foe into an ally for nanomedicine. Nat Reviews Mater 9(4):219\u2013222","journal-title":"Nat Reviews Mater"},{"issue":"4","key":"5194_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics9040186","volume":"9","author":"D Hammoudi Halat","year":"2020","unstructured":"Hammoudi Halat D, Ayoub Moubareck C (2020) The current burden of carbapenemases: review of significant properties and dissemination among gram-negative bacteria. Antibiotics (Basel) 9(4):186","journal-title":"Antibiotics (Basel)"},{"issue":"8","key":"5194_CR53","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1089\/mdr.2017.0165","volume":"24","author":"Z Hamzaoui","year":"2018","unstructured":"Hamzaoui Z et al (2018) An outbreak of NDM-1-producing Klebsiella pneumoniae, associated with OmpK35 and OmpK36 porin loss in Tunisia. Microb Drug Resist 24(8):1137\u20131147","journal-title":"Microb Drug Resist"},{"issue":"5","key":"5194_CR54","doi-asserted-by":"publisher","first-page":"231","DOI":"10.21608\/bjas.2021.205383","volume":"6","author":"MG Hassan","year":"2021","unstructured":"Hassan MG et al (2021) Silver nanoparticles as antibacterial agent aganist multidrug resistant Klbsiella pneumoni. Benha J Appl Sci 6(5):231\u2013235","journal-title":"Benha J Appl Sci"},{"key":"5194_CR55","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2022.957572","author":"F Hejabi","year":"2022","unstructured":"Hejabi F et al (2022) Nanocarriers: a novel strategy for the delivery of CRISPR\/Cas systems. Front Chem. https:\/\/doi.org\/10.3389\/fchem.2022.957572","journal-title":"Front Chem"},{"issue":"1","key":"5194_CR56","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3390\/biomedicines13010129","volume":"13","author":"HF Hetta","year":"2025","unstructured":"Hetta HF, Ramadan YN, Al-Kadmy IMS (2025) Editorial for special issue antibiotic combination therapy: a strategy to overcome bacterial resistance. Biomedicines 13(1):129","journal-title":"Biomedicines"},{"issue":"2","key":"5194_CR57","doi-asserted-by":"publisher","first-page":"413","DOI":"10.3390\/biomedicines11020413","volume":"11","author":"HF Hetta","year":"2023","unstructured":"Hetta HF et al (2023) Nanotechnology as a promising approach to combat multidrug resistant bacteria: a comprehensive review and future perspectives. Biomedicines 11(2):413","journal-title":"Biomedicines"},{"issue":"15","key":"5194_CR58","doi-asserted-by":"publisher","first-page":"3466","DOI":"10.3390\/molecules29153466","volume":"29","author":"HF Hetta","year":"2024","unstructured":"Hetta HF et al (2024) Quorum sensing inhibitors: an alternative strategy to win the battle against multidrug-resistant (MDR) bacteria. Molecules 29(15):3466","journal-title":"Molecules"},{"issue":"5","key":"5194_CR59","doi-asserted-by":"publisher","first-page":"724","DOI":"10.3390\/ph18050724","volume":"18","author":"HF Hetta","year":"2025","unstructured":"Hetta HF et al (2025) Hypervirulent Klebsiella pneumoniae: insights into virulence, antibiotic resistance, and fight strategies against a superbug. Pharmaceuticals 18(5):724","journal-title":"Pharmaceuticals"},{"key":"5194_CR60","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-026-02752-8","author":"HF Hetta","year":"2026","unstructured":"Hetta HF et al (2026) Targeting antimicrobial resistance through vaccinology: a review of preclinical and clinical pipeline vaccines against WHO priority bacterial pathogens. Infection. https:\/\/doi.org\/10.1007\/s15010-026-02752-8","journal-title":"Infection"},{"issue":"2","key":"5194_CR61","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3390\/ph18020206","volume":"18","author":"Y-S Huang","year":"2025","unstructured":"Huang Y-S, Zhou H (2025) Breakthrough advances in beta-lactamase inhibitors: new synthesized compounds and mechanisms of action against drug-resistant bacteria. Pharmaceuticals 18(2):206","journal-title":"Pharmaceuticals"},{"issue":"1","key":"5194_CR62","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/s41392-024-01745-z","volume":"9","author":"Y Huang","year":"2024","unstructured":"Huang Y et al (2024) Nanotechnology\u2019s frontier in combatting infectious and inflammatory diseases: prevention and treatment. Signal Transduct Target Therapy 9(1):34","journal-title":"Signal Transduct Target Therapy"},{"issue":"8","key":"5194_CR63","doi-asserted-by":"publisher","first-page":"5633","DOI":"10.1021\/acssensors.5c00508","volume":"10","author":"L Huang","year":"2025","unstructured":"Huang L et al (2025) Absolute quantitative detection of hypervirulent Klebsiella pneumoniae using a novel silicon-doped carbon quantum dot-probe-graphene oxide. ACS Sens 10(8):5633\u20135643","journal-title":"ACS Sens"},{"issue":"5","key":"5194_CR64","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.7150\/thno.82790","volume":"13","author":"L Jiang","year":"2023","unstructured":"Jiang L, Ding L, Liu G (2023) Nanoparticle formulations for therapeutic delivery, pathogen imaging and theranostic applications in bacterial infections. Theranostics 13(5):1545\u20131570","journal-title":"Theranostics"},{"issue":"6","key":"5194_CR65","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1021\/acs.molpharmaceut.1c00916","volume":"19","author":"P Kazemian","year":"2022","unstructured":"Kazemian P et al (2022) Lipid-nanoparticle-based delivery of CRISPR\/Cas9 genome-editing components. Mol Pharm 19(6):1669\u20131686","journal-title":"Mol Pharm"},{"key":"5194_CR66","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.ijid.2020.02.005","volume":"93","author":"A Khalid","year":"2020","unstructured":"Khalid A et al (2020) Characterizing the role of porin mutations in susceptibility of beta lactamase producing Klebsiella pneumoniae isolates to ceftaroline and ceftaroline-avibactam. Int J Infect Dis 93:252\u2013257","journal-title":"Int J Infect Dis"},{"key":"5194_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2023.114708","volume":"194","author":"M Kumar","year":"2023","unstructured":"Kumar M et al (2023) Nanoparticle biodistribution coefficients: a quantitative approach for understanding the tissue distribution of nanoparticles. Adv Drug Deliv Rev 194:114708","journal-title":"Adv Drug Deliv Rev"},{"key":"5194_CR68","doi-asserted-by":"publisher","DOI":"10.3389\/fnano.2024.1479993","author":"RV Kumarasamy","year":"2024","unstructured":"Kumarasamy RV et al (2024) Clinical applications and therapeutic potentials of advanced nanoparticles: a comprehensive review on completed human clinical trials. Front Nanotech. https:\/\/doi.org\/10.3389\/fnano.2024.1479993","journal-title":"Front Nanotech"},{"key":"5194_CR69","doi-asserted-by":"publisher","first-page":"102071","DOI":"10.1016\/j.mtbio.2025.102071","volume":"33","author":"I Laib","year":"2025","unstructured":"Laib I et al (2025) Tailoring innovative silver nanoparticles for modern medicine: the importance of size and shape control and functional modifications. Mater Today Bio 33:102071","journal-title":"Mater Today Bio"},{"key":"5194_CR70","doi-asserted-by":"publisher","first-page":"9395","DOI":"10.2147\/IJN.S216204","volume":"14","author":"B Lallo da Silva","year":"2019","unstructured":"Lallo da Silva B et al (2019) Relationship between structure and antimicrobial activity of zinc oxide nanoparticles: an overview. Int J Nanomedicine 14:9395\u20139410","journal-title":"Int J Nanomedicine"},{"key":"5194_CR71","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jgar.2021.02.020","volume":"25","author":"P Lan","year":"2021","unstructured":"Lan P et al (2021) A global perspective on the convergence of hypervirulence and carbapenem resistance in Klebsiella pneumoniae. J Global Antimicrob Resist 25:26\u201334","journal-title":"J Global Antimicrob Resist"},{"key":"5194_CR72","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S453025","author":"Y Li","year":"2024","unstructured":"Li Y, Kumar S, Zhang L (2024) Mechanisms of antibiotic resistance and developments in therapeutic strategies to combat Klebsiella pneumoniae infection. Infect Drug Resist. https:\/\/doi.org\/10.2147\/IDR.S453025","journal-title":"Infect Drug Resist"},{"issue":"1","key":"5194_CR73","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13756-019-0489-3","volume":"8","author":"J Li","year":"2019","unstructured":"Li J et al (2019) The nature and epidemiology of OqxAB, a multidrug efflux pump. Antimicrob Resist Infect Control 8(1):44","journal-title":"Antimicrob Resist Infect Control"},{"key":"5194_CR74","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.2147\/IDR.S509016","volume":"18","author":"J Li","year":"2025","unstructured":"Li J et al (2025) Mechanisms of antimicrobial resistance in Klebsiella: advances in detection methods and clinical implications. Infect Drug Resist 18:1339\u20131354","journal-title":"Infect Drug Resist"},{"key":"5194_CR75","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2025.1555617","volume":"15","author":"K Li","year":"2025","unstructured":"Li K et al (2025) Aptamer-functionalized graphene quantum dots combined with artificial intelligence detect bacteria for urinary tract infections. Front Cell Infect Microbiol 15:1555617","journal-title":"Front Cell Infect Microbiol"},{"key":"5194_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2025.126501","volume":"689","author":"K Li","year":"2026","unstructured":"Li K et al (2026) Advances in metal ion\u2013mediated macromolecular drug delivery. Int J Pharm 689:126501","journal-title":"Int J Pharm"},{"key":"5194_CR77","doi-asserted-by":"publisher","first-page":"5983","DOI":"10.2147\/IJN.S519183","volume":"20","author":"L Li","year":"2025","unstructured":"Li L et al (2025) Photothermal antibacterial effect of gold nanostars coating on titanium implant and its osteogenic performance. Int J Nanomed 20:5983\u20135999","journal-title":"Int J Nanomed"},{"key":"5194_CR78","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.jconrel.2024.11.044","volume":"377","author":"W Li","year":"2025","unstructured":"Li W et al (2025) Stimuli-responsive and targeted nanomaterials: revolutionizing the treatment of bacterial infections. J Controlled Release 377:495\u2013523","journal-title":"J Controlled Release"},{"key":"5194_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.nantod.2022.101505","volume":"44","author":"J Liu","year":"2022","unstructured":"Liu J et al (2022) Peptide-based nano-antibiotic transformers with antibiotic adjuvant effect for multidrug resistant bacterial pneumonia therapy. Nano Today 44:101505","journal-title":"Nano Today"},{"issue":"3","key":"5194_CR80","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1021\/acsinfecdis.5c00988","volume":"12","author":"Y Liu","year":"2026","unstructured":"Liu Y et al (2026) Recent advances in pleuromutilin derivatives as antimicrobial agents (2015\u20132025). ACS Infect Dis 12(3):946\u2013966","journal-title":"ACS Infect Dis"},{"key":"5194_CR81","doi-asserted-by":"publisher","first-page":"1533952","DOI":"10.3389\/fphar.2025.1533952","volume":"16","author":"W-M Long","year":"2025","unstructured":"Long W-M et al (2025) The efficacy and safety of ceftazidime\/avibactam or polymyxin B based regimens for carbapenem-resistant Pseudomonas aeruginosa infection: a multicenter real-world and propensity score-matched study. Front Pharmacol 16:1533952","journal-title":"Front Pharmacol"},{"issue":"10","key":"5194_CR82","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1089\/mdr.2020.0395","volume":"27","author":"F Lv","year":"2021","unstructured":"Lv F et al (2021) Overexpression of efflux pumps mediate pan resistance of Klebsiella Pneumoniae sequence type 11. Microb Drug Resist 27(10):1405\u20131411","journal-title":"Microb Drug Resist"},{"key":"5194_CR83","doi-asserted-by":"publisher","DOI":"10.1016\/j.ntm.2024.100034","volume":"3","author":"J Lv","year":"2024","unstructured":"Lv J et al (2024) Photothermal\/photodynamic antibacterial hydrogel embedded with copper carbon dots and Au nanoparticles. Nano Transmed 3:100034","journal-title":"Nano Transmed"},{"issue":"9","key":"5194_CR84","doi-asserted-by":"publisher","first-page":"844","DOI":"10.3390\/antibiotics13090844","volume":"13","author":"HLRdQ Mac\u00eado","year":"2024","unstructured":"Mac\u00eado HLRdQ et al (2024) Nanostructures for delivery of flavonoids with antibacterial potential against Klebsiella pneumoniae. Antibiotics 13(9):844","journal-title":"Antibiotics"},{"issue":"7","key":"5194_CR85","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1021\/acsinfecdis.2c00649","volume":"9","author":"A Mayorga-Ramos","year":"2023","unstructured":"Mayorga-Ramos A et al (2023) CRISPR-cas-based antimicrobials: design, challenges, and bacterial mechanisms of resistance. ACS Infect Dis 9(7):1283\u20131302","journal-title":"ACS Infect Dis"},{"key":"5194_CR86","doi-asserted-by":"publisher","first-page":"1823476","DOI":"10.3389\/fmicb.2026.1823476","volume":"17","author":"A Mbaraka","year":"2026","unstructured":"Mbaraka A et al (2026) Targeting biofilm-driven antibiotic resistance: emerging mechanisms and next-generation therapeutic interventions. Front Microbiol 17:1823476","journal-title":"Front Microbiol"},{"key":"5194_CR87","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2024.101354","volume":"29","author":"L Mei","year":"2024","unstructured":"Mei L et al (2024) Nanomaterials at the forefront of antimicrobial therapy by photodynamic and photothermal strategies. Mater Today Bio 29:101354","journal-title":"Mater Today Bio"},{"issue":"1","key":"5194_CR88","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.1038\/s41598-022-06657-y","volume":"12","author":"CR Mendes","year":"2022","unstructured":"Mendes CR et al (2022) Antibacterial action and target mechanisms of zinc oxide nanoparticles against bacterial pathogens. Sci Rep 12(1):2658","journal-title":"Sci Rep"},{"issue":"3","key":"5194_CR89","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1128\/MMBR.00012-07","volume":"71","author":"M Miethke","year":"2007","unstructured":"Miethke M, Marahiel MA (2007) Siderophore-based iron acquisition and pathogen control. Microbiol Mol Biol Rev 71(3):413\u2013451","journal-title":"Microbiol Mol Biol Rev"},{"issue":"17","key":"5194_CR90","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22179652","volume":"22","author":"V Miku\u0161ov\u00e1","year":"2021","unstructured":"Miku\u0161ov\u00e1 V, Miku\u0161 P (2021) Advances in chitosan-based nanoparticles for drug delivery. Int J Mol Sci 22(17):9652","journal-title":"Int J Mol Sci"},{"key":"5194_CR91","doi-asserted-by":"publisher","DOI":"10.1093\/lambio\/ovae136","author":"AA Mohamed","year":"2024","unstructured":"Mohamed AA et al (2024) A combined therapy of meropenem\u2013ZnO nanoparticles efficiently eliminates carbapenem-resistant Klebsiella pneumoniae biofilms, with reduced nephrotoxicity (in vitro). Lett Appl Microbiol. https:\/\/doi.org\/10.1093\/lambio\/ovae136","journal-title":"Lett Appl Microbiol"},{"issue":"1","key":"5194_CR92","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-99230-y","volume":"11","author":"MA Mohammed","year":"2021","unstructured":"Mohammed MA et al (2021) Impact of target site mutations and plasmid associated resistance genes acquisition on resistance of Acinetobacter baumannii to fluoroquinolones. Sci Rep 11(1):20136","journal-title":"Sci Rep"},{"issue":"3","key":"5194_CR93","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1039\/D4PM00032C","volume":"1","author":"SK Mondal","year":"2024","unstructured":"Mondal SK et al (2024) Antimicrobial nanoparticles: current landscape and future challenges. RSC Pharm 1(3):388\u2013402","journal-title":"RSC Pharm"},{"issue":"1","key":"5194_CR94","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s13568-024-01720-5","volume":"14","author":"FM Mosallam","year":"2024","unstructured":"Mosallam FM, Elshimy R (2024) Eradication of Klebsiella pneumoniae pulmonary infection by silver oxytetracycline nano-structure. AMB Express 14(1):62","journal-title":"AMB Express"},{"key":"5194_CR95","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkaf422","author":"R Mostafa","year":"2026","unstructured":"Mostafa R et al (2026) Nanoparticle-based co-delivery of ciprofloxacin and meropenem enhances synergistic activity against multidrug-resistant hypervirulent Klebsiella pneumoniae clinical isolates. J Antimicrob Chemother. https:\/\/doi.org\/10.1093\/jac\/dkaf422","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"5194_CR96","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1002\/jobm.202200612","volume":"63","author":"SM Mousavi","year":"2023","unstructured":"Mousavi SM et al (2023) Evaluation of biosynthesized silver nanoparticles effects on expression levels of virulence and biofilm-related genes of multidrug-resistant Klebsiella pneumoniae isolates. J Basic Microbiol 63(6):632\u2013645","journal-title":"J Basic Microbiol"},{"issue":"4","key":"5194_CR97","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1101\/gr.279329.124","volume":"35","author":"R Munro","year":"2025","unstructured":"Munro R et al (2025) Enhancing nanopore adaptive sampling for PromethION using readfish at scale. Genome Res 35(4):877\u2013885","journal-title":"Genome Res"},{"key":"5194_CR98","doi-asserted-by":"publisher","DOI":"10.1016\/j.slasd.2025.100232","volume":"33","author":"G Muteeb","year":"2025","unstructured":"Muteeb G et al (2025) Antimicrobial resistance: linking molecular mechanisms to public health impact. SLAS Discov 33:100232","journal-title":"SLAS Discov"},{"key":"5194_CR99","doi-asserted-by":"publisher","DOI":"10.3389\/fmats.2024.1449614","author":"J Nan","year":"2024","unstructured":"Nan J et al (2024) Research on the antibacterial properties of nanoscale zinc oxide particles comprehensive review. Front Mater. https:\/\/doi.org\/10.3389\/fmats.2024.1449614","journal-title":"Front Mater"},{"issue":"11","key":"5194_CR100","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.3390\/antibiotics13111029","volume":"13","author":"R Papa-Ezdra","year":"2024","unstructured":"Papa-Ezdra R et al (2024) First detection of high-level aminoglycoside-resistant Klebsiella pneumoniae and enterobacter cloacae isolates due to 16S rRNA methyltransferases with and without blaNDM in Uruguay. Antibiotics 13(11):1029","journal-title":"Antibiotics"},{"key":"5194_CR101","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.msec.2018.04.093","volume":"90","author":"V Pareek","year":"2018","unstructured":"Pareek V, Gupta R, Panwar J (2018) Do physico-chemical properties of silver nanoparticles decide their interaction with biological media and bactericidal action? A review. Mater Sci Eng C Mater Biol Appl 90:739\u2013749","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"5194_CR102","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.638640","volume":"12","author":"V Pareek","year":"2021","unstructured":"Pareek V et al (2021) Silver nanoparticles induce a triclosan-like antibacterial action mechanism in multi-drug resistant Klebsiella pneumoniae. Front Microbiol 12:638640","journal-title":"Front Microbiol"},{"issue":"2","key":"5194_CR103","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3390\/antibiotics14020207","volume":"14","author":"N Parvin","year":"2025","unstructured":"Parvin N, Joo SW, Mandal TK (2025) Nanomaterial-based strategies to combat antibiotic resistance: mechanisms and applications. Antibiotics 14(2):207","journal-title":"Antibiotics"},{"key":"5194_CR104","doi-asserted-by":"publisher","DOI":"10.1128\/msphere.00428-20","author":"T Pedersen","year":"2020","unstructured":"Pedersen T et al (2020) Horizontal plasmid transfer among Klebsiella pneumoniae isolates is the key factor for dissemination of extended-spectrum \u03b2-lactamases among children in Tanzania. mSphere. https:\/\/doi.org\/10.1128\/msphere.00428-20","journal-title":"mSphere"},{"issue":"8","key":"5194_CR105","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1017\/ice.2019.106","volume":"40","author":"LRR Perez","year":"2019","unstructured":"Perez LRR (2019) Equal, but different: fluctuant biofilm formation and its impact on polymyxin B susceptibility among a clonal spreading of KPC-2\u2013producing Klebsiella pneumoniae isolates. Infect Control Hosp Epidemiol 40(8):954\u2013955","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"5","key":"5194_CR106","doi-asserted-by":"publisher","first-page":"501","DOI":"10.2217\/17460913.2.5.501","volume":"2","author":"L Poirel","year":"2007","unstructured":"Poirel L, Pitout JD, Nordmann P (2007) Carbapenemases: molecular diversity and clinical consequences. Future Microbiol 2(5):501\u2013512","journal-title":"Future Microbiol"},{"issue":"21","key":"5194_CR107","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.1016\/j.scib.2023.09.040","volume":"68","author":"D Pu","year":"2023","unstructured":"Pu D et al (2023) Superbugs with hypervirulence and carbapenem resistance in Klebsiella pneumoniae: the rise of such emerging nosocomial pathogens in China. Sci Bull 68(21):2658\u20132670","journal-title":"Sci Bull"},{"issue":"3","key":"5194_CR108","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1128\/CMR.00001-07","volume":"20","author":"AM Queenan","year":"2007","unstructured":"Queenan AM, Bush K (2007) Carbapenemases: the versatile \u03b2-lactamases. Clin Microbiol Rev 20(3):440\u2013458","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"5194_CR109","doi-asserted-by":"publisher","DOI":"10.1016\/j.jksus.2021.101731","volume":"34","author":"G Rajivgandhi","year":"2022","unstructured":"Rajivgandhi G et al (2022) Biosynthesized zinc oxide nanoparticles (ZnO NPs) using actinomycetes enhance the anti-bacterial efficacy against K. Pneumoniae. J King Saud Univ Sci 34(1):101731","journal-title":"J King Saud Univ Sci"},{"issue":"11","key":"5194_CR110","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.3109\/13880209.2014.893001","volume":"52","author":"LS Reddy","year":"2014","unstructured":"Reddy LS et al (2014) Antimicrobial activity of zinc oxide (ZnO) nanoparticle against Klebsiella pneumoniae. Pharm Biol 52(11):1388\u20131397","journal-title":"Pharm Biol"},{"issue":"1","key":"5194_CR111","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1186\/s12866-024-03383-5","volume":"24","author":"S Rezaei","year":"2024","unstructured":"Rezaei S et al (2024) Investigation of gyrA and parC mutations and the prevalence of plasmid-mediated quinolone resistance genes in Klebsiella pneumoniae clinical isolates. BMC Microbiol 24(1):265","journal-title":"BMC Microbiol"},{"key":"5194_CR112","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.00776-18","author":"TA Russo","year":"2018","unstructured":"Russo TA et al (2018) Identification of biomarkers for differentiation of hypervirulent Klebsiella pneumoniae from classical K. pneumoniae. J Clin Microbiol. https:\/\/doi.org\/10.1128\/jcm.00776-18","journal-title":"J Clin Microbiol"},{"issue":"9","key":"5194_CR113","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00776-18","volume":"56","author":"TA Russo","year":"2018","unstructured":"Russo TA et al (2018) Identification of biomarkers for differentiation of hypervirulent Klebsiella pneumoniae from classical K. pneumoniae. J Clin Microbiol 56(9):e00776-18","journal-title":"J Clin Microbiol"},{"issue":"10","key":"5194_CR114","doi-asserted-by":"publisher","first-page":"950","DOI":"10.3390\/antibiotics13100950","volume":"13","author":"S Sabtcheva","year":"2024","unstructured":"Sabtcheva S et al (2024) Genomic characterization of 16S rRNA methyltransferase-producing enterobacterales reveals the emergence of Klebsiella pneumoniae ST6260 Harboring rmtF, rmtB, blaNDM-5, blaOXA-232 and blaSFO-1 genes in a cancer hospital in Bulgaria. Antibiotics 13(10):950","journal-title":"Antibiotics"},{"key":"5194_CR115","doi-asserted-by":"publisher","DOI":"10.1016\/j.colcom.2024.100804","volume":"62","author":"M Saed","year":"2024","unstructured":"Saed M et al (2024) Gold nanoparticles antibacterial activity: does the surface matter? Colloid Interface Sci Commun 62:100804","journal-title":"Colloid Interface Sci Commun"},{"issue":"4","key":"5194_CR116","doi-asserted-by":"publisher","first-page":"3664","DOI":"10.1007\/s11837-026-08220-w","volume":"78","author":"RA Saeed","year":"2026","unstructured":"Saeed RA et al (2026) Vancomycin adsorption, anti-oxidant, antimicrobial, and anticancer properties of green-synthesized CeO2 and TiO2 NPs: a comparative study. JOM 78(4):3664\u20133686","journal-title":"JOM"},{"issue":"1","key":"5194_CR117","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-025-04323-4","volume":"23","author":"A Saffari Natanzi","year":"2025","unstructured":"Saffari Natanzi A et al (2025) Innovative approaches to combat antibiotic resistance: integrating CRISPR\/Cas9 and nanoparticles against biofilm-driven infections. BMC Med 23(1):486","journal-title":"BMC Med"},{"issue":"3","key":"5194_CR118","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics18030369","volume":"18","author":"A Salama","year":"2026","unstructured":"Salama A et al (2026) Myrrh oil-based nanoemulsion loaded with curcumin and insulin: development, characterization, and evaluation of enhanced antibacterial and diabetic wound-healing activity. Pharmaceutics 18(3):369","journal-title":"Pharmaceutics"},{"issue":"5","key":"5194_CR119","doi-asserted-by":"publisher","first-page":"4301","DOI":"10.1007\/s11837-025-08053-z","volume":"78","author":"BAA Saleem","year":"2026","unstructured":"Saleem BAA et al (2026) Witch Hazel-Derived ZnO nanoparticles: green synthesis and exceptional multifunctionality in antibiotic removal, inflammation control, bacterial inhibition, and colorectal\/breast cancer suppression. JOM 78(5):4301\u20134324","journal-title":"JOM"},{"key":"5194_CR120","doi-asserted-by":"publisher","DOI":"10.1016\/j.impact.2022.100385","volume":"25","author":"A S\u00e1nchez Jim\u00e9nez","year":"2022","unstructured":"S\u00e1nchez Jim\u00e9nez A et al (2022) Safe(r) by design guidelines for the nanotechnology industry. NanoImpact 25:100385","journal-title":"NanoImpact"},{"key":"5194_CR121","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2025.114204","author":"P Savadi","year":"2025","unstructured":"Savadi P et al (2025) Nanotechnology-based approaches to tackle bacterial infections. J Control Release. https:\/\/doi.org\/10.1016\/j.jconrel.2025.114204","journal-title":"J Control Release"},{"issue":"6","key":"5194_CR122","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1159\/000464275","volume":"62","author":"E Savov","year":"2017","unstructured":"Savov E et al (2017) Colistin resistance in KPC-2-and SHV-5-producing Klebsiella pneumoniae clinical isolates in Bulgaria. Chemotherapy 62(6):339\u2013342","journal-title":"Chemotherapy"},{"issue":"4","key":"5194_CR123","doi-asserted-by":"publisher","first-page":"756","DOI":"10.3390\/antibiotics12040756","volume":"12","author":"S Scandorieiro","year":"2023","unstructured":"Scandorieiro S et al (2023) Antibiofilm effect of biogenic silver nanoparticles combined with oregano derivatives against carbapenem-resistant Klebsiella pneumoniae. Antibiotics 12(4):756","journal-title":"Antibiotics"},{"issue":"1","key":"5194_CR124","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12951-017-0262-9","volume":"15","author":"MI Shaaban","year":"2017","unstructured":"Shaaban MI, Shaker MA, Mady FM (2017) Imipenem\/cilastatin encapsulated polymeric nanoparticles for destroying carbapenem-resistant bacterial isolates. J Nanobiotechnol 15(1):29","journal-title":"J Nanobiotechnol"},{"issue":"5","key":"5194_CR125","doi-asserted-by":"publisher","first-page":"3858","DOI":"10.1039\/D4RA07519F","volume":"15","author":"S Shahzadi","year":"2025","unstructured":"Shahzadi S et al (2025) A review on green synthesis of silver nanoparticles (SNPs) using plant extracts: a multifaceted approach in photocatalysis, environmental remediation, and biomedicine. RSC Adv 15(5):3858\u20133903","journal-title":"RSC Adv"},{"issue":"1","key":"5194_CR126","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12866-017-1148-6","volume":"18","author":"C Shankar","year":"2018","unstructured":"Shankar C et al (2018) Whole genome analysis of hypervirulent Klebsiella pneumoniae isolates from community and hospital acquired bloodstream infection. BMC Microbiol 18(1):6","journal-title":"BMC Microbiol"},{"key":"5194_CR127","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.875116","volume":"12","author":"C Shankar","year":"2022","unstructured":"Shankar C et al (2022) Hybrid plasmids encoding antimicrobial resistance and virulence traits among hypervirulent Klebsiella pneumoniae ST2096 in India. Front Cell Infect Microbiol 12:875116","journal-title":"Front Cell Infect Microbiol"},{"key":"5194_CR128","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.926363","volume":"12","author":"A Shariati","year":"2022","unstructured":"Shariati A et al (2022) PLGA-based nanoplatforms in drug delivery for inhibition and destruction of microbial biofilm. Front Cell Infect Microbiol 12:926363","journal-title":"Front Cell Infect Microbiol"},{"key":"5194_CR129","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2024.1391345","volume":"15","author":"D Sharma","year":"2024","unstructured":"Sharma D et al (2024) Unveiling the nanoworld of antimicrobial resistance: integrating nature and nanotechnology. Front Microbiol 15:1391345","journal-title":"Front Microbiol"},{"issue":"11","key":"5194_CR130","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1086\/648077","volume":"49","author":"HE Sidjabat","year":"2009","unstructured":"Sidjabat HE et al (2009) Interspecies spread of Klebsiella pneumoniae carbapenemase gene in a single patient. Clin Infect Dis 49(11):1736\u20131738","journal-title":"Clin Infect Dis"},{"issue":"1","key":"5194_CR131","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1186\/s12951-025-03712-4","volume":"23","author":"H Singh","year":"2025","unstructured":"Singh H et al (2025) Smart hybrid nanomaterials for chronic infections: microbiome-responsive and sustainable therapeutic platforms. J Nanobiotechnol 23(1):698","journal-title":"J Nanobiotechnol"},{"key":"5194_CR132","first-page":"451","volume":"67","author":"A Singh","year":"2022","unstructured":"Singh A et al (2022) TeO2 deposited ZnO nanotubes combined with cefotaxime as a nanoantibiotic against Klebsiella pneumoniae. Mater Today: Proc 67:451\u2013455","journal-title":"Mater Today: Proc"},{"issue":"3","key":"5194_CR133","first-page":"219","volume":"7","author":"A Sirelkhatim","year":"2015","unstructured":"Sirelkhatim A et al (2015) Review on zinc oxide nanoparticles: antibacterial activity and toxicity mechanism. Nanomicro Lett 7(3):219\u2013242","journal-title":"Nanomicro Lett"},{"key":"5194_CR134","doi-asserted-by":"publisher","DOI":"10.3390\/polym13050724","author":"VA Spirescu","year":"2021","unstructured":"Spirescu VA et al (2021) Polymeric nanoparticles for antimicrobial therapies: an up-to-date overview. Polymers (Basel). https:\/\/doi.org\/10.3390\/polym13050724","journal-title":"Polymers (Basel)"},{"key":"5194_CR135","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics12061044","author":"K Stojowska-Sw\u0119drzy\u0144ska","year":"2023","unstructured":"Stojowska-Sw\u0119drzy\u0144ska K, Kuczy\u0144ska-Wi\u015bnik D, Laskowska E (2023) New strategies to kill metabolically-dormant cells directly bypassing the need for active cellular processes. Antibiotics (Basel). https:\/\/doi.org\/10.3390\/antibiotics12061044","journal-title":"Antibiotics (Basel)"},{"key":"5194_CR136","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2026.1735885","volume":"14","author":"F Stucchi","year":"2026","unstructured":"Stucchi F et al (2026) Regulatory framework for polymer-based nanotherapeutics in clinical translation. Front Bioeng Biotechnol 14:1735885","journal-title":"Front Bioeng Biotechnol"},{"issue":"1","key":"5194_CR137","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-59866-y","volume":"14","author":"M Szymczak","year":"2024","unstructured":"Szymczak M et al (2024) An effective antibiofilm strategy based on bacteriophages armed with silver nanoparticles. Sci Rep 14(1):9088","journal-title":"Sci Rep"},{"issue":"6","key":"5194_CR138","doi-asserted-by":"publisher","first-page":"394","DOI":"10.30802\/AALAS-CM-22-000024","volume":"72","author":"SJ Taetzsch","year":"2022","unstructured":"Taetzsch SJ et al (2022) Melioidosis in Cynomolgus Macaques (Macaca Fascicularis) imported to the United States from Cambodia. Comp Med 72(6):394\u2013402","journal-title":"Comp Med"},{"issue":"6","key":"5194_CR139","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1021\/acssynbio.4c00070","volume":"13","author":"BA Taha","year":"2024","unstructured":"Taha BA et al (2024) Synergizing nanomaterials and artificial intelligence in advanced optical biosensors for precision antimicrobial resistance diagnosis. ACS Synth Biol 13(6):1600\u20131620","journal-title":"ACS Synth Biol"},{"key":"5194_CR140","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2020.104244","volume":"147","author":"M Tang","year":"2020","unstructured":"Tang M et al (2020) The role and relationship with efflux pump of biofilm formation in Klebsiella pneumoniae. Microb Pathog 147:104244","journal-title":"Microb Pathog"},{"issue":"1","key":"5194_CR141","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1186\/s12951-025-03333-x","volume":"23","author":"S Thangudu","year":"2025","unstructured":"Thangudu S, Su CH (2025) Review of light activated antibacterial nanomaterials in the second biological window. J Nanobiotechnol 23(1):293","journal-title":"J Nanobiotechnol"},{"key":"5194_CR142","doi-asserted-by":"publisher","first-page":"1545678","DOI":"10.3389\/fmed.2025.1545678","volume":"12","author":"T Tian","year":"2025","unstructured":"Tian T et al (2025) A systematic review of hypervirulent Klebsiella pneumoniae research: bibliometric and topic modeling perspectives. Front Med (Lausanne) 12:1545678","journal-title":"Front Med (Lausanne)"},{"issue":"4","key":"5194_CR143","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1021\/acsabm.2c00014","volume":"5","author":"N Tripathi","year":"2022","unstructured":"Tripathi N, Goshisht MK (2022) Recent advances and mechanistic insights into antibacterial activity, antibiofilm activity, and cytotoxicity of silver nanoparticles. ACS Appl Bio Mater 5(4):1391\u20131463","journal-title":"ACS Appl Bio Mater"},{"issue":"4","key":"5194_CR144","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1128\/AAC.01275-10","volume":"55","author":"YK Tsai","year":"2011","unstructured":"Tsai YK et al (2011) Klebsiella pneumoniae outer membrane porins OmpK35 and OmpK36 play roles in both antimicrobial resistance and virulence. Antimicrob Agents Chemother 55(4):1485\u20131493","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"5194_CR145","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/s41579-019-0294-2","volume":"18","author":"J Vergalli","year":"2020","unstructured":"Vergalli J et al (2020) Porins and small-molecule translocation across the outer membrane of Gram-negative bacteria. Nat Rev Microbiol 18(3):164\u2013176","journal-title":"Nat Rev Microbiol"},{"issue":"3","key":"5194_CR146","doi-asserted-by":"publisher","first-page":"743","DOI":"10.3390\/pathogens3030743","volume":"3","author":"C Vuotto","year":"2014","unstructured":"Vuotto C et al (2014) Antibiotic resistance related to biofilm formation in Klebsiella pneumoniae. Pathogens 3(3):743\u2013758","journal-title":"Pathogens"},{"issue":"4","key":"5194_CR147","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1111\/jam.13533","volume":"123","author":"C Vuotto","year":"2017","unstructured":"Vuotto C et al (2017) Biofilm formation and antibiotic resistance in Klebsiella pneumoniae urinary strains. J Appl Microbiol 123(4):1003\u20131018","journal-title":"J Appl Microbiol"},{"key":"5194_CR148","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2019.00872","volume":"7","author":"DY Wang","year":"2019","unstructured":"Wang DY et al (2019) Lipid-based antimicrobial delivery-systems for the treatment of bacterial infections. Front Chem 7:872","journal-title":"Front Chem"},{"issue":"3","key":"5194_CR149","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0173638","volume":"12","author":"L Wang","year":"2017","unstructured":"Wang L et al (2017) Resistance of hypervirulent Klebsiella pneumoniae to both intracellular and extracellular killing of neutrophils. PLoS One 12(3):e0173638","journal-title":"PLoS One"},{"key":"5194_CR150","doi-asserted-by":"publisher","DOI":"10.1016\/j.scitotenv.2023.169590","volume":"914","author":"J Wang","year":"2024","unstructured":"Wang J et al (2024) Modulating the toxicity of engineered nanoparticles by controlling protein corona formation: recent advances and future prospects. Sci Total Environ 914:169590","journal-title":"Sci Total Environ"},{"issue":"1","key":"5194_CR151","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1186\/s12951-024-02576-4","volume":"22","author":"H Wang","year":"2024","unstructured":"Wang H et al (2024) Phage-based delivery systems: engineering, applications, and challenges in nanomedicines. J Nanobiotechnol 22(1):365","journal-title":"J Nanobiotechnol"},{"issue":"1","key":"5194_CR152","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12951-025-03126-2","volume":"23","author":"X Wang","year":"2025","unstructured":"Wang X et al (2025) Photodynamic and photothermal bacteria targeting nanosystems for synergistically combating bacteria and biofilms. J Nanobiotechnol 23(1):40","journal-title":"J Nanobiotechnol"},{"issue":"6","key":"5194_CR153","doi-asserted-by":"publisher","first-page":"3290","DOI":"10.1128\/AAC.00310-15","volume":"59","author":"MHY Wong","year":"2015","unstructured":"Wong MHY, Chan EWC, Chen S (2015) Evolution and dissemination of OqxAB-like efflux pumps, an emerging quinolone resistance determinant among members of Enterobacteriaceae. Antimicrob Agents Chemother 59(6):3290\u20133297","journal-title":"Antimicrob Agents Chemother"},{"key":"5194_CR154","doi-asserted-by":"publisher","DOI":"10.1007\/s00284-026-04747-y","author":"DR Wozeak","year":"2026","unstructured":"Wozeak DR et al (2026) Biogenic silver nanoparticles: an antibacterial and antibiofilm approach to control carbapenem-resistant Klebsiella pneumoniae. Curr Microbiol. https:\/\/doi.org\/10.1007\/s00284-026-04747-y","journal-title":"Curr Microbiol"},{"issue":"61, 2021","key":"5194_CR155","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1146\/annurev-pharmtox-032320-110338","volume":"61","author":"W Yang","year":"2021","unstructured":"Yang W et al (2021) Nanoparticle toxicology. Annu Rev Pharmacol Toxicol 61(61, 2021):269\u2013289","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"5194_CR156","doi-asserted-by":"publisher","first-page":"903","DOI":"10.2147\/IDR.S505311","volume":"18","author":"Y Yang","year":"2025","unstructured":"Yang Y et al (2025) Effectiveness of omadacycline in a patient with Chlamydia psittaci and KPC-producing gram-negative bacteria infection. Infect Drug Resist 18:903\u2013908","journal-title":"Infect Drug Resist"},{"issue":"2","key":"5194_CR157","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1128\/JCM.01150-06","volume":"45","author":"K-M Yeh","year":"2007","unstructured":"Yeh K-M et al (2007) Capsular serotype K1 or K2, rather than magA and rmpA, is a major virulence determinant for Klebsiella pneumoniae liver abscess in Singapore and Taiwan. J Clin Microbiol 45(2):466\u2013471","journal-title":"J Clin Microbiol"},{"issue":"1","key":"5194_CR158","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-025-08095-8","volume":"8","author":"K Yi","year":"2025","unstructured":"Yi K et al (2025) Amphiphilic mPEG-PLGA copolymer nanoparticles co-delivering colistin and niclosamide to treat colistin-resistant Gram-negative bacteria infections. Commun Biol 8(1):673","journal-title":"Commun Biol"},{"key":"5194_CR159","doi-asserted-by":"publisher","first-page":"114083","DOI":"10.1016\/j.addr.2021.114083","volume":"181","author":"MA Younis","year":"2022","unstructured":"Younis MA et al (2022) Clinical translation of nanomedicines: challenges, opportunities, and keys. Adv Drug Deliv Rev 181:114083","journal-title":"Adv Drug Deliv Rev"},{"key":"5194_CR160","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.671153","volume":"12","author":"Q Zhang","year":"2021","unstructured":"Zhang Q et al (2021) Characterization of tigecycline-heteroresistant Klebsiella pneumoniae clinical isolates from a Chinese tertiary care teaching hospital. Front Microbiol 12:671153","journal-title":"Front Microbiol"},{"key":"5194_CR161","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116627","volume":"175","author":"T Zhao","year":"2024","unstructured":"Zhao T et al (2024) Engineering the protein corona: strategies, effects, and future directions in nanoparticle therapeutics. Biomed Pharmacother 175:116627","journal-title":"Biomed Pharmacother"},{"key":"5194_CR162","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.729300","author":"Y Zhou","year":"2021","unstructured":"Zhou Y et al (2021) Stimuli-responsive nanoplatform-assisted photodynamic therapy against bacterial infections. Front Med. https:\/\/doi.org\/10.3389\/fmed.2021.729300","journal-title":"Front Med"},{"issue":"1","key":"5194_CR163","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s15010-024-02324-8","volume":"53","author":"H-H Zhuang","year":"2025","unstructured":"Zhuang H-H et al (2025) Ceftazidime\/avibactam versus polymyxin B in carbapenem-resistant Klebsiella pneumoniae infections: a propensity score-matched multicenter real-world study. Infection 53(1):95\u2013106","journal-title":"Infection"},{"issue":"13","key":"5194_CR164","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph17134657","volume":"17","author":"A Zieli\u0144ska","year":"2020","unstructured":"Zieli\u0144ska A et al (2020) Nanotoxicology and nanosafety: safety-by-design and testing at a glance. Int J Environ Res Public Health 17(13):4657","journal-title":"Int J Environ Res Public Health"},{"key":"5194_CR165","doi-asserted-by":"publisher","DOI":"10.3390\/ijms262211202","author":"B Ziemba","year":"2025","unstructured":"Ziemba B (2025) Advances in cytotoxicity testing: from in vitro assays to in silico models. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms262211202","journal-title":"Int J Mol Sci"}],"container-title":["Archives of Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-026-05194-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00203-026-05194-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-026-05194-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T22:01:49Z","timestamp":1790460109000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00203-026-05194-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,26]]},"references-count":165,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["5194"],"URL":"https:\/\/doi.org\/10.1007\/s00203-026-05194-w","relation":{},"ISSN":["0302-8933","1432-072X"],"issn-type":[{"value":"0302-8933","type":"print"},{"value":"1432-072X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,26]]},"assertion":[{"value":"6 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Institutional review board statement","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"667"}}